fbpx

Move to U.S. Manufacturing Boosts CooperVision Biofinity Toric Multifocal Delivery Speed by 50%

CooperVision has accelerated North American delivery times by more than 50% of all Biofinity® toric multifocal contact lenses for U.S. and Canadian customers after transitioning the manufacturing to its New York production facility in late 2022. All trial lenses and six-packs of the made-to-order lenses now originate from CooperVision’s technologically advanced facility in Scottsville, N.Y., reaching Canadian customers in 10 to 15 days, on average.

“CooperVision’s made-to-order advantage enables us to offer highly customized contact lenses in very little time,” said Brian Filan, Director of Marketing, Canada. “By moving Biofinity® toric multifocal production from the U.K. to the U.S. for our North American customers, we make and deliver these sophisticated lenses to our customers and their patients even faster—with most orders shipping in just a few days.”

Biofinity® toric multifocal orders for other markets continue to be manufactured at CooperVision’s U.K. facility.

Click HERE for the full press release.

Featured Posts

SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read More
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read More
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read More
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read More
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more
SILMO Paris 2024

Discover the Winner of the Optical Design Contest

The Optical Design Contest is intended to be a stepping stone for the next generation, and an opportunity for them to stimulate their creativity through a responsible design approach.

Learn More
EssilorLuxottica

EssilorLuxottica Unveils Plans for Its New Corporate Headquarters in Paris

EssilorLuxottica announced the signing of a long-term pre-letting agreement for its new global headquarters in Paris, expected to open late 2027.

Read more
contact lens institute

Reminder: Contact Lens Institute Culture Awards Nominations Due

The nominating period for the second annual Contact Lens Institute™ (CLI) Culture Awards ends October 1.

Read more
CooperVision

CooperVision Delivers Broad Range of Myopia Research at the 60th International Myopia Conference

Company Illustrates Its Scientific and Clinical Leadership in Transforming the Future of Children’s Vision

Read more
SightGlass Vision

IMC 2024: Multiple Studies Reinforce SightGlass Vision Diffusion Optics Technology™ Efficacy for Myopia Management

New Clinical and Patient Data Deepens Confidence in Ability to Slow Myopia Progression without a Rebound Effect, Builds Foundational Knowledge for Researcher and Clinicians

Read more